Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
259 Leser
Artikel bewerten:
(1)

The Insight Partners: With 8.2% CAGR Adenosine Triphosphate (ATP) Swab Test Market is Projected to Reach US$ 369.71 Million by 2027

NEW YORK, Nov. 12, 2021 /PRNewswire/ -- According to The Insight Partners study on "Adenosine Triphosphate (ATP) Swab Test Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Type and Application," the market was valued at US$ 198.21 million in 2019 and is projected to reach US$ 369.71 million by 2027; it is expected to grow at a CAGR of 8.2% during 2020-2027. The market growth is attributed to the rising prevalence of healthcare-associated infections (HAIs) and increasing emphasis on food safety. However, limitations of ATP swab tests are hindering the market growth.

The_Insight_Partners_Logo

Get Exclusive Sample Pages of Adenosine Triphosphate (ATP) Swab Test Market - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00014433/

Rising Prevalence of HAIs Fuels Adenosine Triphosphate (ATP) Swab Test Market Growth

HAIs might be acquired by people during their visit to healthcare facilities. These infections are mainly spread through surgical procedures and medical instruments used during procedures. HAIs may lead to morbidity among significant number of patients as well as high number of mortalities across the world. According to a study published by the Centers for Disease Control and Prevention (CDC) in 2019, 1 in 31 hospital patients is estimated to suffer from some kind of HAI. In addition, according to estimates by the European Centre for Disease Prevention and Control in 2019, ~4.1 million patients in Europe suffer from HAIs every year. Furthermore, according to a study published in the journal of Antimicrobial Resistance & Infection Control in 2019, the incidence rate of HAIs in China was 3.62 per 1,000 patient days. The respiratory tract infections accounted for 43.80% of these HAI cases, while bloodstream and urinary tract infections accounted for 15.74% and 12.69%, respectively. Further, the increasing prevalence of chronic conditions and infectious disease outbreaks is projected to accelerate the hospital visits and patient pool in years to come, which would also lead to the rise in number of HAIs cases. As per estimates published by the World Health Organization (WHO) in 2019, 421 million hospitalizations are conducted worldwide each year. Out of these hospitalizations, 42.7 million patients suffer due to adverse reactions or infections at healthcare settings. Thus, the increase in incidence of HAIs due to various factors is fueling the ATP swab testing market growth.

Download Sample PDF Brochure of Adenosine Triphosphate (ATP) Swab Test Market Growth Research Report athttps://www.theinsightpartners.com/sample/TIPRE00014433/

Report Coverage

Details

Market Size Value in

US$ 198.21 million in 2019

Market Size Value by

US$ 369.71 Million by 2027

Growth rate

CAGR of 8.2% from 2020 to 2027

Forecast Period

2020 - 2027

Base Year

2020

No. of Pages

153

No. Tables

55

No. of Charts & Figures

67

Historical data available

Yes

Segments covered

Type, Application, End User

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Adenosine Triphosphate (ATP) Swab Test Market: Segmental Overview

On the basis of type, the adenosine triphosphate (ATP) swab test market is segmented into free ATP test and microbial ATP test. The microbial ATP test segment held a larger market share in 2019; and it is anticipated to register the highest CAGR in the market during the forecast period. Microbial ATP test for hygiene monitoring provides a measurement of the direct risks related to the presence of high microbial levels; it is also a measure of unintended risks resulting from organic scums that can serve as a source of nutrients for microorganisms.

On the basis of application, the adenosine triphosphate (ATP) swab test market is segmented into pharmaceutical and biotechnology companies, food and beverages industry, hospitals and diagnostics laboratories, and academic and research institutions. The pharmaceutical and biotechnology companies segment held the largest market share in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. These companies prefer using the adenosine triphosphate (ATP) swab test for a quick assessment of the cleanliness of surfaces or liquid samples obtained from places such as Clean-in-Place (CIP) systems. Thus, these tests allow the pharmaceutical and biotechnology companies to cut down resource allocation for conventional microbiological testing methods that are slow, labor intensive, and costly.

Adenosine Triphosphate (ATP) Swab Test Market: Competition Landscape & Key Developments

Hygiena, Llc; 3M; Charm Sciences, Inc.; Kikkoman Biochemifa; Neogen; Ecolab; Ruhof Healthcare Corporation; Luminultra Technologies Ltd.; and Merck KGaA are key companies operating in the adenosine triphosphate (ATP) swab test market. The market leaders are continuously looking forward to expanding and diversifying their market presence and reaching out to new customers, thus tapping prevailing business opportunities.

Buy Copy of Adenosine Triphosphate (ATP) Swab Test Market Research Study at https://www.theinsightpartners.com/buy/TIPRE00014433/

In November 2020, Ecolab Food & Beverage North America partnered with Hygiena to help advance our customers' hygiene monitoring and food safety programs. This partnership is likely to bring together Hygiena's game-changing EnSURE Touch ATP system.

In December 2018, AOAC-RI provided Hygiena's product for its Performance Tested MethodSM certificate to the UltraSnap Surface ATP Test that assist in identifying the possible presence of microbial contamination.

In 2019, North America dominated the adenosine triphosphate (ATP) swab test market with more than one-third revenue share. The growth of the market in this region is attributed to the growing burden of COVID-19 diagnosis across various countries, which is boosting the ATP swab test demands. Similarly, the increasing prevalence of HAIs and rising demand for sanitation are also boosting the market growth.

Browse Related Reports and get Sample copy

Drive Through COVID-19 Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Throat Swab Testing, Nose Swab Testing); End User (Personal, Group), and Geography - https://www.theinsightpartners.com/sample/TIPRE00012614/

Medical Sterile Swabs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Cotton Tipped Swabs, Foam Tipped Swabs, Non- woven Swabs, and Others); End-User (Hospital, Clinics, Diagnostic Laboratories, and Others), and Geography - https://www.theinsightpartners.com/sample/TIPRE00013466/

Sterile Alcohol Swabs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type (Foam Tipped Swabs, Cotton Tipped Swabs.Non-woven, Others); End User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare Settings, Others), and Geography - https://www.theinsightpartners.com/sample/TIPRE00013484/

Disposable Flocking Swab Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Standard Type, Mini Type, Separable Type, Others); Application (Hospital, Clinic, Laboratory, Others) - https://www.theinsightpartners.com/sample/TIPRE00021163/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release - https://www.theinsightpartners.com/pr/malaria-treatment-market
More Research: https://www.openpr.com/news/archive/139407/The-Insight-Partners.html

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2021 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.